| Accord Healthcare AG - Deferasirox Accord 360 mg, Filmtabletten | | 67517 | | 03 | | Deferasirox Accord 360 mg | | Filmtabletten | | V03AC03 | | Deferasirox | | 01.02.2021 | | |
| | Composition | | deferasiroxum 360 mg, cellulosum microcristallinum, carmellosum natricum conexum, hydroxypropylcellulosum substitutum humile, poloxamerum 188, povidonum K 30, lactosum monohydricum 108.1 mg, silica colloidalis anhydrica, natrii stearylis fumaras, ricini oleum hydrogenatum, Überzug: hypromellosum, propylenglycolum, talcum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 2.1788 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Déférasirox | 360 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Déférasirox | 360 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 108.1 mg | | | Natrii Stearylis Fumaras | | | | Poloxamer | 188 | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Propylenglycol | | | | Ricini Oleum Hydrogenatum | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
